Yingdong Zhu

2.3k citations
54 papers · 1.9k indexed · h-index 26
Topics
Liver Disease Diagnosis and Treatment (14 papers)Ginger and Zingiberaceae research (9 papers)Cholesterol and Lipid Metabolism (7 papers)
Partner nations
United StatesChinaQatar

In The Last Decade

Yingdong Zhu

54 papers receiving 1.8k citations

Peers

Yingdong Zhu
Comparison fields: 5 of 111
  • Molecular Biology 675
  • Epidemiology 303
  • Biochemistry 276
  • Clinical Biochemistry 237
  • Pharmacology 233
Replace Hicham Berrougui with:
Hicham Berrougui Canada
Naisheng Bai United States
Christine Boesch‐Saadatmandi Germany
Jae Heun Lee South Korea
Raosaheb K. Kale India
Ping‐Hsiao Shih Taiwan
Chan Hum Park South Korea
Joanna Kołodziejczyk-Czepas Poland
Opeyemi Joshua Olatunji China
Akira Asai Japan
Yingdong Zhu relative to Hicham Berrougui Canada Hicham Berrougui's profile →
Citations per field
00.5×
Hicham Berrougui · 1×
Citations per year

Countries citing papers authored by Yingdong Zhu

Since Specialization
Citations

This map shows the geographic impact of Yingdong Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingdong Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingdong Zhu more than expected).

Fields of papers citing papers by Yingdong Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingdong Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingdong Zhu. The network helps show where Yingdong Zhu may publish in the future.

Co-authorship network of co-authors of Yingdong Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yingdong Zhu. A scholar is included among the top collaborators of Yingdong Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingdong Zhu. Yingdong Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 7
3 13
4 6
5 15
6 6
7 56
8 64
9 97
10 103
11 24
12 74
13 40
14 31
15 32
16 65
17 38
18 7
19 7
20 27

About Yingdong Zhu

Yingdong Zhu is a scholar working on Pharmacology, Clinical Biochemistry and Biochemistry, having authored 54 papers that have together received 1.9k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (14 papers), Ginger and Zingiberaceae research (9 papers) and Cholesterol and Lipid Metabolism (7 papers). The work is most often cited by research in Biochemistry (276 citations), Clinical Biochemistry (237 citations) and Pharmacology (233 citations). Yingdong Zhu has collaborated with scholars based in United States, China and Qatar. Frequent co-authors include Shengmin Sang, Yanyong Xu, Huadong Chen, Yanqiao Zhang, Liya Yin, Dominique N. Soroka, Yantao Zhao, Rashin Sedighi, Junsheng Fu and Shuwei Hu. Their work appears in journals such as Hepatology, Cancer Research and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026